Código QR (código de barras bidimensional)

The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1<sup>+</sup> Cells

Inhibition of the prolyl-4-hydroxylase domain (PHD) enzymes, leading to the stabilization of hypoxia-inducible factor (HIF) α as well as to the stimulation of erythropoietin (Epo) synthesis, is the functional mechanism of the new anti-anemia drug roxadustat. Little is known about the effects of roxa...

תיאור מלא

שמור ב:
Principais autores: Aline Jatho, Anke Zieseniss, Katja Brechtel-Curth, Jia Guo, Kai Oliver Böker, Gabriela Salinas, Roland H. Wenger, Dörthe M. Katschinski
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2022-02-01
סדרה:Cells
נושאים:
HIFα-stabilizing drugs
PHD inhibitor
roxadustat
erythropoietin
Sca-1
גישה מקוונת:https://www.mdpi.com/2073-4409/11/4/753
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים